Bone morphogenetic proteins

Blood

Volumn 114, Issue 10, 2009, Pages 2012-2013

  Towler, Dwight A ^a  

^a WASHINGTON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BONE MORPHOGENETIC PROTEIN; BONE MORPHOGENETIC PROTEIN 2; BONE MORPHOGENETIC PROTEIN 4;

ANGIOGENESIS; BLOOD FLOW; BONE DEVELOPMENT; CELL FUNCTION; CELL PROLIFERATION; CIRCULATION; ENDOCRINE FUNCTION; ENDOTHELIUM CELL; GENETIC LINKAGE; HOMEOSTASIS; HUMAN; MOLECULAR GENETICS; NONHUMAN; NOTE; OSSIFICATION; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN PURIFICATION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; WOUND HEALING;

EID: 70449464402     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2009-06-228544     Document Type: Note

References (14)

1. Shao ES, Lin L, Yao Y, Boström KI. Expression of vascular endothelial growth factor is coordinately regulated by the activin-like kinase receptors 1 and 5 in endothelial cells. Blood. 2009;114(10):2197-2206.
2. Urist MR. Bone: formation by autoinduction. Science. 1965;150(3698):893- 899.
3. Van de Putte KA, Urist MR. Osteogenesis in the interior of intramuscular implants of decalcified bone matrix. Clin Orthop Relat Res. 1965;43:257-270.
4. Wozney JM, Rosen V, Celeste AJ, et al. Novel regulators of bone formation: molecular clones and activities. Science. 1988;242(4885):1528-1534. (Pubitemid 19023695)
5. Daluiski A, Engstrand T, Bahamonde ME, et al. Bone morphogenetic protein-3 is a negative regulator of bone density. Nat Genet. 2001;27(1):84-88. (Pubitemid 32044524)
6. Camaschella C. BMP6 orchestrates iron metabolism. Nat Genet. 2009;41(4):386-388.
7. Abdalla SA, Letarte M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet. 2006;43(2):97-110. (Pubitemid 43262964)
8. David L, Mallet C, Mazerbourg S, Feige JJ, Bailly S. Identification of BMP9 and BMP10 as functional activators of the orphan activin receptor-like kinase 1 (ALK1) in endothelial cells. Blood. 2007;109(5):1953-1961. (Pubitemid 46348192)
9. David L, Mallet C, Keramidas M, et al. Bone morphogenetic protein-9 is a circulating vascular quiescence factor. Circ Res. 2008;102(8):914-922. (Pubitemid 351591550)
10. Scharpfenecker M, van Dinther M, Liu Z, et al. BMP-9 signals via ALK1 and inhibits bFGF-induced endothelial cell proliferation and VEGF-stimulated angiogenesis. J Cell Sci. 2007;120(pt. 6):964-972. (Pubitemid 46638511)
11. Luo G, Ducy P, McKee MD, et al. Spontaneous calcification of arteries and cartilage in mice lacking matrix GLA protein. Nature. 1997;386(6620):78-81. (Pubitemid 27130923)
12. Bostrom K, Tsao D, Shen S, Wang Y, Demer LL. Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem. 2001;276(17):14044-14052. (Pubitemid 37391788)
13. Yao Y, Nowak S, Yochelis A, Garfinkel A, Bostrom KI. Matrix GLA protein, an inhibitory morphogen in pulmonary vascular development. J Biol Chem. 2007;282(41):30131-30142. (Pubitemid 350035283)
14. Guise TA, Chirgwin JM. Transforming growth factor-beta in osteolytic breast cancer bone metastases [review]. Clin Orthop Relat Res. October 2003;(suppl 415):S32-S38.